Elite in HIV/AIDS

Claudine Duvivier

Paris, FR 
Elite in HIV/AIDS
Paris, FR 
OverviewLocationsClinical Research

Overview

Claudine Duvivier practices in Paris, France. Ms. Duvivier is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Hepatitis, Hepatitis C, and Anal Cancer.

Her clinical research consists of co-authoring 106 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 75 articles and participated in 6 clinical trials in the study of HIV/AIDS.

Gender
Female

Locations

Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination
Microbiome-based Stratification of Individuals at Risk of HIV-1 Acquisition, Chronic Clinical Complications, Antimicrobial Drug Resistance, and Unresponsiveness to Therapeutic HIV-1 Vaccination
Enrollment Status: Active_not_recruiting
Publish Date: April 11, 2025
A Prospective Study Aiming to Determine the Cartography of Virological Reservoir Related to Antiretroviral Concentrations in Chronic HIV-1 Patients Treated with a First Line of Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors (NRTIs).
A Prospective Study Aiming to Determine the Cartography of Virological Reservoir Related to Antiretroviral Concentrations in Chronic HIV-1 Patients Treated with a First Line of Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors (NRTIs).
Enrollment Status: Completed
Publish Date: September 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
Combined Prevention of Sexually Transmitted Infections (STIs) in Men Who Have Sex With Men and Using Oral Tenofovir Disoproxil Fumarate/ Emtricitabine (TDF/FTC) for HIV Pre-Exposure Prophylaxis (PrEP)
Enrollment Status: Completed
Publish Date: July 30, 2024
Intervention Type: Biological, Drug
Study Drugs: Doxycycline, Bexsero® vaccine
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
A Phase III, Randomized, Multicenter, Parallel-group, Non-inferiority Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Dolutegravir Plus Lamivudine in HIV-1 Infected Adults Who Are Virologically Suppressed
Enrollment Status: Completed
Publish Date: July 19, 2023
Intervention Type: Drug
Study Drugs: Dolutegravir+Lamivudine, Tenofovir alafenamide based regimen
Study Phase: Phase 3
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma
Enrollment Status: Completed
Publish Date: May 01, 2023
Prevention of HIV in Île-de-France
Prevention of HIV in Île-de-France
Enrollment Status: Unknown
Publish Date: June 02, 2022
Intervention Type: Drug
Study Phase: Not Applicable
View 5 Less Clinical Trials

106 Total Publications

Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
Journal: The Journal of antimicrobial chemotherapy
Published: June 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Duvivier's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile